Nurse Anesthetist - CR in Eden, NC Accepting Medicare

8 Nurse Anesthetist - CR nurses found. Showing 1 - 8

Heidi Orme, MS, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 117 E Kings Hwy, Eden, NC 27288 Phone: 336-623-9711

Ms. Maria Iyabodei Sorinolu-famuyiwa, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 117 E Kings Hwy, Eden, NC 27288 Phone: 336-623-9711

Linda N. Haynes, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 117 E Kings Hwy, Eden, NC 27288 Phone: 336-623-9711    Fax: 336-623-7660

Jane Everhart Bowman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 117 E Kings Hwy, Eden, NC 27288 Phone: 336-623-9711

Janet J. Davis, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 117 E Kings Hwy, Eden, NC 27288 Phone: 336-623-9711    Fax: 336-623-7660

Donald C Wray, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 117 E Kings Hwy, Eden, NC 27288 Phone: 336-623-9711    Fax: 336-623-7660

Ms. Annie Delores Blackwell, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 117 E Kings Hwy, Eden, NC 27288 Phone: 336-623-9711

Charles Garcia, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 117 E. Kings Highway, Eden, NC 27288 Phone: 336-623-9711    Fax: 336-623-7660

News Archive

QIAGEN receives first companion diagnostic approval in Japan

QIAGEN N.V. today announced that the Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's VIZIMPRO (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer.

PharmAthene to provide update on contract modification suspension

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that in addition to its year end results, it will provide an update on the contract modification suspension it received on Friday, March 19, 2010.

Study: Diagnosed levels of psychosis and anxiety more severe among men in Hackney

Excess psychosis diagnoses amongst Black and South Asian men in deprived urban areas could reflect a cluster of disadvantage in specific places, rather than individual experiences of deprivation alone, a study led by Queen Mary University of London researchers concludes.

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS).

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life. So when new, more efficient treatment methods are developed, one important question is whether better treatment comes at the cost of increased side effects and decreased quality of life.

Read more Medical News

› Verified 2 days ago